Amarillo Pathology Group L.L.P.

Amarillo Pathology Group L.L.P., doing business as Todd, Robert M MD, is a for-profit limited-liability pathology medical practice based in Amarillo, Texas that provides surgical pathology, cytology, bone marrow examinations, frozen sections, consultations, and quality assurance services to the Department of Veterans Affairs as a prime contractor on a 100% prime-award footprint with no subcontract activity. The vendor operates under total small business set-aside designation on its core indefinite-delivery contract vehicle and competes full-and-open on individual delivery orders; it is a Subchapter S corporation with no stated SBA 8(a), HUBZone, SDVOSB, or women-owned certifications.

Amarillo Pathology Group's federal customer base is entirely within the Veterans Health Administration, with 15 awards ($16.3 million combined potential value) directed to Veterans Integrated Service Network 17 (the Amarillo VA Health Care System) and 5 awards ($848 thousand) directed to Veterans Integrated Service Network 22. The two VHA networks account for 20 of 32 total awards and 86% of combined potential value, representing near-total concentration in VA pathology support. Work is performed in Amarillo, Texas; the vendor has maintained a VA relationship since SAM.gov registration in 2004 and has delivered delivery orders annually or bi-annually across the past several years.

The vendor holds five active indefinite-delivery contracts. The primary vehicle is an April 2024 single-award total small business set-aside IDC with Veterans Integrated Service Network 17, ceiling $2.681 million through March 31, 2025 with four one-year option periods available. Against this contract, the vendor has received three task orders: a base-year delivery order of $371,444.87 (April 1, 2024 through April 30, 2025), an Option Year 1 modification of $446,935.30 (April 1, 2025 through March 31, 2026), and a subsequent Option Year 1 delivery order of $446,935.30 (April 1, 2026 through March 31, 2027). The vendor also places task orders under four additional IDCs with Veterans Integrated Service Network 17 and Veterans Integrated Service Network 22, ranging from two to seven task orders per vehicle and carrying combined potential values from $255 thousand to $5.3 million. Scope encompasses surgical pathology, cytology, bone marrow examinations, Pap smears, frozen sections, CPT coding, case review, on-call coverage, quality assurance documentation, and contractor-furnished equipment.

Activity has been sparse and sporadic — one award per year in 2022 and 2023, three in 2024, one in 2025, and one in 2026 — with only one award facing ultimate completion within the next twenty-four months ($447 thousand), indicating minimal near-term recompete exposure. The vendor's footprint reflects a narrow, stable pathology-services practice anchored to a single regional VA facility, with no multi-agency diversification, no subcontractor engagement, and no parent contract vehicles or government-wide acquisition contracts. Primary NAICS categories are Medical Laboratories (20 awards) and Offices of Physicians except Mental Health Specialists (12 awards); primary PSC is Medical—Pathology (30 awards).